J0717 is the HCPCS code for: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered). In 2024, 958 providers billed J0717 61,165,045 times, with an estimated $220.1M paid by Medicare.
J0717 is a Part B drug code: Medicare pays an ASP-based rate of $3.44 per 1 mg (2026 Q3 ASP drug pricing file). Total payment per patient depends on the dose billed.
A billed "service" on this code is one 1 mg unit, not one patient visit — that's why the service counts below run high.
What Medicare actually paid per service in 2024, on average: $3.60 (observed payment across all settings and modifiers — not a fee-schedule rate).
The top 5 billers nationally, ranked by 2024 Medicare service volume.
| # | Provider | Specialty | Location | Services | Est. Medicare paid |
|---|---|---|---|---|---|
| 1 | Vinicius Costa Diniz Domingues, M.D. | Rheumatology | Daytona Beach, FL | 1,090,240 | $3.9M |
| 2 | Nehal Gandhi, MD | Rheumatology | Glen Mills, PA | 507,600 | $1.8M |
| 3 | Mohamed Aboyoussef, M.D. | Rheumatology | Merritt Island, FL | 443,200 | $1.6M |
| 4 | William Chafin, M.D. | Rheumatology | Gainesville, GA | 316,401 | $1.1M |
| 5 | Vipul Joshi, MD | Rheumatology | Brandon, FL | 310,400 | $1.1M |
Prospect 811 answers "what is this code, what does it pay, and who bills it?" for every billable code — then filters the answer to your exact territory, with phone numbers. $79/month, no contract, 14-day refund.
Start prospecting →